Neuramancer Lands €1.7m Pre-seed To Scale Deepfake Detection Tools

Neuramancer AI Solutions GmbH (formerly Neuraforge) has closed a €1.7 million pre-seed funding round led by Vanagon Ventures, with participation from Bayern Kapital and a group of additional venture capital firms and business angels. The investment consortium also includes the Nuremberg-based ZOHO.VC and family office Lightfield Equity. In addition, the founding team is supported by senior executives from the financial services and big-tech sectors, as well as experienced platform founders acting as business angels.

Deepfakes and other forms of AI-generated media manipulation are increasingly recognised as a risk for both businesses and society. According to the German Insurance Association (GdV), insurance fraud results in billions of euros in damages each year, with generative AI contributing to new forms of manipulation, such as altered damage images and manipulated video calls. As AI models continue to improve, identifying such forgeries is becoming more challenging.

Based on several years of research, Neuramancer has developed a detection technology designed to identify statistical irregularities in image and video noise. The system focuses on structural artifacts rather than semantic content, which the company says enables it to detect manipulations that may be difficult to identify using conventional AI-based detection methods.

In addition to detection, the platform generates forensic analysis reports that show how and where media may have been altered, providing insights that can support fraud investigation and prevention.

Co-founder Anika Gruner said the market for deepfake detection is still in its early stages but is expected to grow significantly in the coming years, while regulatory requirements for transparent and trustworthy AI systems are also increasing.

While many providers rely on intransparent black-box models, we pursue a scientifically grounded, fully transparent approach. For us, it is clear: European, explainable AI will become a strategic competitive advantage for companies that need to protect themselves against synthetic manipulation.

The new funding will be used to scale Neuramancer’s deepfake detection platform, expand the company’s team, and support commercialisation and market expansion, with an initial focus on the insurance industry.